Dementia Global Clinical Trials Review 2024: Comparative Scenario of Completed and Uncompleted (Terminated, Suspended, Withdrawn) Trials
July 02, 2024 09:49 ET
|
Research and Markets
Dublin, July 02, 2024 (GLOBE NEWSWIRE) -- The "Dementia - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The analyst's clinical trial...
Alopecia Global Clinical Trials Review 2024: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End-Point Status
July 01, 2024 09:55 ET
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Alopecia - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides...
Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review 2024: Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type
July 01, 2024 09:52 ET
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
Clinical Trials Project Management Course: Data Integrity and Quality, Compliance Requirements, Project Objectives, Comprehensive Planning (ON-DEMAND)
June 27, 2024 09:56 ET
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Project Management as applied to Clinical Trials" training has been added to ResearchAndMarkets.com's offering.Clinical trial project management...
Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome
June 27, 2024 08:00 ET
|
Quoin Pharmaceuticals, Inc.
Clinical site to be Opened in Saudi Arabia Site Currently Treating Netherton Patients Who Are Eligible for Recruitment into Quoin Studies Experienced Local Clinical Research Organization Has...
INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial
June 27, 2024 08:00 ET
|
INmune Bio, Inc.
The planned interim analysis confirms the accuracy of the sample size calculations and statistical power for EMACC, the primary endpoint. The interim analysis, performed by a third-party,...
Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference
June 25, 2024 16:05 ET
|
Quoin Pharmaceuticals, Inc.
ASHBURN, Va., June 25, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan...
Antibody-drug Conjugates Shift the Cancer Treatment Landscape: Novotech Whitepaper Examines Latest Clinical Trial Data
June 21, 2024 17:30 ET
|
Novotech
BOSTON, June 21, 2024 (GLOBE NEWSWIRE) -- Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of...
Global LAG-3 Inhibitors Market, Drug Sales & Clinical Trials Market Report: Featuring Abeome, ABL Bio, Agenus, Akeso Biopharma, AnaptysBio, EpimAb Biotherapeutics, Immutep, Incyte and Y-Biologics
June 20, 2024 04:23 ET
|
Research and Markets
Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Global LAG-3 Inhibitors Market, Drug Sales & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering. In recent...
Alira Health Partners with Scottsdale Research Institute for Psilocybin Clinical Trials Funded by the State of Arizona
June 18, 2024 09:00 ET
|
Alira Health
Framingham, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- Alira Health, a global advisory and clinical research firm, announced today its collaboration with the Scottsdale Research Institute (SRI) to...